홈 › 유방암 › 일리노이

일리노이의 유방암 임상 시험

유방암 관련 연구 81개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.

일리노이의 도시

공식 연구 텍스트(영어)

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Orchard Healthcare Research Inc.- Skokie, Skokie

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06324357

PRE-ISPY Phase I/II Oncology Platform Program

The University of Chicago Medicine Comprehensive Cancer Center, Chicago
UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
UChicago Medicine Orland Park, Orland Park

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT05868226

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Northwestern Medicine Chicago Proton Center, Warrenville

피험자 모집 중2상

50세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT01766297

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Affiliated Oncologists IL, Chicago
Hope And Healing Care, Hinsdale

피험자 모집 중3상

18세 ~ 100세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05827081

Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment

The University of Chicago Medicine Comprehensive Cancer Center, Chicago

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07553234

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

City of Hope Chicago, Zion

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07007559

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Rush University Medical Center ( Site 0079), Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312176

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

University of Illinois Cancer Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06172478

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Peoria
Clinical Trial Site, Urbana

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Northwestern University, Chicago

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

City of Hope, Chicago, Chicago
Northwestern Memorial Hospital, Chicago
University of Illinois at Chicago, Chicago
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

University of Chicago, Chicago

피험자 모집 중건강한 지원자 환영

30세 ~ 74세 · 여성 · 2026. 9. 21. 업데이트됨 · NCT02620852

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

City of Hope, Chicago, Zion

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07109726

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Cancer Care Specialists, Decatur
Cancer Care Specialists of Illinois, O'Fallon
Carle Foundation Hospital d/b/a Carle Cancer Center, Urbana

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07173751

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

University of Illinois Hospital & Health Sciences System, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06827236

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Illinois Cancer Specialists, Arlington Heights
Northwestern Memorial Hospital, Chicago
RUSH MD Anderson Cancer Center, Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

Orchard Healthcare Research Inc., Skokie

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05935384

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

University of Illinois Cancer Center, Chicago
University of Chicago Medicine, Chicago
City of Hope - Chicago, Zion

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

City of Hope® Cancer Center Chicago, Zion

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT03424005

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Orchard Healthcare Research Inc. ( Site 0006), Skokie

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06797635

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Carle Cancer Center, Urbana

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT05386108

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

NorthShore University Health System - Evanston Hospital, Evanston
NorthShore University HealthSystem - Evanston Hospital, Evanston
Duly Health and Care, Lisle
외 2개

피험자 모집 중1상

18세 ~ 55세 · 여성 · 2026. 9. 9. 업데이트됨 · NCT07310420

A Phase 1/1b Study of IAM1363 in HER2 Cancers

University of Chicago, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

City of Hope® Cancer Center Chicago, Zion

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07100106

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Research Site, Evanston

피험자 모집 중3상

18세 ~ 130세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07647328

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Northwestern University, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT05315700

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Northwestern University, Chicago
Rush University Medical Center, Chicago
University of Chicago, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06062498

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Rush University Medical Center, Chicago
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06982521

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Southern Illinois Hospital Services, Carbondale
Cancer Care Specialist of Illinois, O'Fallon

피험자 모집 중관찰 연구

18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07211178

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Cancer Care Specialists of Central Illinois, O'Fallon
Springfield Clinic, Springfield
Carle Cancer Center, Urbana
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06790693

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

University of Illinois Cancer Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT04886531

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Northwestern University, Chicago
Southern Illinois University-Simmons, Springfield
Carle Foundation Cancer Institute-Urbana, Urbana

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
외 54개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

OSF Saint Anthony's Health Center, Alton
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
외 83개

피험자 모집 중3상

18세 ~ 60세 · 여성 · 2026. 9. 2. 업데이트됨 · NCT05879926

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

University Of Chicago Medicine Comprehensive Cancer Center, Chicago

피험자 모집 중건강한 지원자 환영

25세 이상 · 여성 · 2026. 9. 1. 업데이트됨 · NCT03729115

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

University of Chicago Medical Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06533826

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

Robert H. Lurie Comprehensive Cancer Center Northwestern University, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06764940

BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer

University of Illinois, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06441890

ATEMPT 2.0: Adjuvant T-DM1 vs TH

The University of Chicago Medical Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04893109

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.